AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Gliclastar-M 30 Tablet

Prescription Icon
Prescription Required

Marketer

Zinnia Life Sciences

Salt Composition

Gliclazide (30mg) + Metformin (500mg)

Overview Gliclastar-M 30 Tablet

DiabetaComb 30, a dual-action antidiabetic medication, manages type 2 diabetes in adults. This formulation combines two agents to regulate blood glucose. Always take DiabetaComb 30 with food, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may adjust based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. DiabetaComb 30 is just one component of a comprehensive diabetes management plan that necessitates a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Common side effects include hypoglycemia (low blood sugar), characterized by symptoms like sweating, dizziness, headache, and tremors; constipation, and vomiting. Learn to recognize and manage hypoglycemia; maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption increases hypoglycemia risk and should be minimized. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. DiabetaComb 30 is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Disclose any history of heart disease to your doctor before starting treatment. Pregnancy or breastfeeding necessitates consultation with your physician prior to use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to assess blood cell counts and liver function.

Primary Ingredients of Gliclastar-M 30 Tablet

No text was provided to rewrite.

Uses of Gliclastar-M 30 Tablet

Adult-onset diabetes

Major Benefits of Gliclastar-M 30 Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Gliclastar-M 30 Tablet with a meal.

Common Side effects of Gliclastar-M 30 Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Gliclastar-M 30 Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Gliclastar-M 30 Tablet should be administered with a meal.

How Gliclastar-M 30 Tablet works:

Gliclazide and metformin are combined in the formulation Gliclastar-M 30 Tablet, an antidiabetic medication.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Gliclastar-M 30 Tablet and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Gliclastar-M 30 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in potentially life-threatening circumstances where a physician determines the potential benefits outweigh the known hazards. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gliclastar-M 30 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Gliclastar-M 30 Tablet cautiously, potentially requiring dosage modification. Consult your physician for guidance. Gliclastar-M 30 Tablet is contraindicated in individuals with severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Gliclastar-M 30 Tablet cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver disease, Gliclastar-M 30 Tablet is typically initiated at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gliclastar-M 30 Tablet :

Should you forget a Gliclastar-M 30 Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Gliclastar-M 30 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Treatment

FAQs on Gliclastar-M 30 Tablet

Gliclastar-M 30 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Gliclastar-M 30 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclastar-M 30 Tablet can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Gliclastar-M 30 Tablet can cause lactic acidosis, a serious medical emergency characterized by high blood lactic acid levels (also known as MALA, or Metformin-associated lactic acidosis). While rare, this side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, or bradycardia. If you experience these, discontinue Gliclastar-M 30 Tablet and seek immediate medical attention.
Prolonged Gliclastar-M 30 Tablet use can lead to vitamin B12 deficiency by interfering with its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Gliclastar-M 30 Tablets are contraindicated in patients with hypersensitivity to any ingredient or excipient. Use is also contraindicated in individuals with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclastar-M 30 Tablet and alcohol is unsafe. This combination may dangerously lower blood sugar and raise the risk of lactic acidosis.
Gliclastar-M 30 Tablet combines gliclazide and metformin to manage type 2 diabetes mellitus in adults. It helps control blood sugar when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Gliclastar-M 30 Tablet may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Gliclastar-M 30 Tablet can cause hypoglycemia (low blood sugar), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice to treat low blood sugar.
Gliclastar-M 30 Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Gliclastar-M 30 Tablet and seek immediate medical attention.
Prolonged Gliclastar-M 30 Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may cause anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Gliclastar-M 30 Tablets are contraindicated in patients with known allergies to any of its components or excipients, and in those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Gliclastar-M 30 Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar and raise the risk of lactic acidosis.
Gliclastar-M 30 Tablet
28
MRP 33
13% off